Alkyl Amines Chemicals Ltd
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
- Market Cap ₹ 8,275 Cr.
- Current Price ₹ 1,618
- High / Low ₹ 2,499 / 1,508
- Stock P/E 46.4
- Book Value ₹ 257
- Dividend Yield 0.62 %
- ROCE 16.5 %
- ROE 12.3 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.0%
- Company has been maintaining a healthy dividend payout of 26.5%
Cons
- The company has delivered a poor sales growth of 11.2% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Allcap Nifty 500 BSE 400 MidSmallCap Index BSE Commodities Nifty MidSmallcap 400
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
366 | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,542 | |
308 | 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,250 | |
Operating Profit | 58 | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 293 |
OPM % | 16% | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% |
1 | 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 23 | |
Interest | 13 | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 2 |
Depreciation | 10 | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 |
Profit before tax | 36 | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 243 |
Tax % | 33% | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | |
24 | 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 179 | |
EPS in Rs | 4.69 | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 34.92 |
Dividend Payout % | 21% | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 5% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 13% |
5 Years: | 12% |
3 Years: | -20% |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | 29% |
5 Years: | 29% |
3 Years: | -18% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | 25% |
5 Years: | 25% |
3 Years: | 19% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 97 | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,302 |
146 | 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 2 | |
79 | 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 391 | |
Total Liabilities | 332 | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,705 |
126 | 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,064 | |
CWIP | 9 | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 33 |
Investments | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 | 0 |
195 | 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 608 | |
Total Assets | 332 | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,705 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
22 | 46 | 61 | 101 | 63 | 102 | 144 | 188 | 364 | 205 | 248 | 275 | |
-27 | -26 | -31 | -35 | -65 | -132 | -67 | -41 | -213 | -206 | -277 | -121 | |
5 | -13 | -36 | -68 | -2 | 32 | -60 | -135 | -86 | -57 | 8 | -140 | |
Net Cash Flow | 0 | 7 | -6 | -2 | -3 | 2 | 17 | 12 | 65 | -58 | -21 | 13 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 76 | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 |
Inventory Days | 141 | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 |
Days Payable | 73 | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 |
Cash Conversion Cycle | 143 | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 |
Working Capital Days | 105 | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 34 | 40 | 46 | 47 |
ROCE % | 21% | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% |
Documents
Announcements
-
Closure of Trading Window
25 Mar - Closure of trading window from April 1, 2025.
-
Announcement Under Regulation 30 (LODR) - Grant Of Esops
20 Mar - Grant of 14,080 stock options to employees.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 19 Mar
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
6 Mar - Disclosure of service tax demand and penalty order.
-
Integrated Filing (Financial)
24 Jan - Integrated financial results for Q3 and nine months ended December 31, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024TranscriptPPT
-
May 2024Transcript PPT REC
-
May 2024TranscriptNotesPPTREC
-
Nov 2023TranscriptPPTREC
-
May 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Jul 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Jun 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Jun 2017TranscriptPPT
-
May 2016TranscriptPPT
Business Leadership
The co. offers 100+ products, it is a global leader in many products including acetonitrile, DEHA, DMA-HCLA, and Triethylamine. [1]